Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Companyâ€™s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

11-05 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
28/10/26	SEK 0.1836	-0.54%	1,273,309
27/10/26	SEK 0.1846	-1.07%	1,437,409
26/10/26	SEK 0.1866	-0.21%	823,648
23/10/26	SEK 0.1870	+2.75%	1,015,475
22/10/26	SEK 0.1820	-5.41%	845,980

Delayed Quote Nasdaq Stockholm

More quotes

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Acarix AB

Company calendar

Market Closed - Nasdaq Stockholm 21:00:00 28/10/2026 +04			5-day change	1st Jan Change
0.1836 ^SEK	-0.54%		-4.28%	-31.49%

10-19	Acarix Wins Saudi Regulatory Nod for Coronary Artery Disease Detection Device	MT
10-19	Acarix AB Receives Regulatory Approval In Saudi Arabia	CI

Market Cap	228M 22.96M 20.6M 19.05M 17.25M 32.23M 2.19B 32.62M 90.72M 1.14B 86.18M 84.36M 3.63B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	228M 22.96M 20.6M 19.05M 17.25M 32.23M 2.19B 32.62M 90.72M 1.14B 86.18M 84.36M 3.63B	EV / Sales 2026 *	16.3x	EV / Sales 2027 *	7.12x
Free-Float	89.13%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Nasdaq Stockholm	ACARIX	Delayed
OTC Markets	ACIXF	Delayed
Deutsche Boerse AG	7AC	Delayed
CBOE		Real-time
CBOE		Real-time

10-19	Acarix Wins Saudi Regulatory Nod for Coronary Artery Disease Detection Device	MT
10-19	Acarix AB Receives Regulatory Approval In Saudi Arabia	CI
09-24	25 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
09-17	Nine stocks have so far today hit new 52-week lows on the Stockholm stock exchange	FW
09-11	Acarix Publishes Peer-Reviewed Study Confirming CADScor System Diagnoses Heart Failure With Fewer False Positives Than Standard Blood Test	CI
08-14	Acarix AB, Q2 2026 Earnings Call, Aug 13, 2026
08-13	Acarix AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-13	Calendar for Thursday, August 13	FW
08-10	Acarix Receives Regulatory Approval For The CADScor System In The UAE	CI
08-10	Acarix Receives UAE Clearance for Point-of-Care Diagnostic Aid	MT
06-17	Acarix AB Announces Directorate Appointments	CI
06-16	Acarix AB Announces That Marlou Janssen-Counott Declines Re-Election as A Member of the Board of Directors	CI
06-12	Calendar Monday June 15 - Friday June 19	FW

Acarix AB Stock

Stocks

ACARIX

SE0009268717

Advanced Medical Equipment & Technology

Valuation: Acarix AB

Chart: Acarix AB

Latest news: Acarix AB

Last Transcript: Acarix AB

Analysts' recommendations: Acarix AB

Press Releases: Acarix AB

Quotes and Performance

Price Extremes

Managers and Directors: Acarix AB

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

10-19	Acarix : receives Regulatory Approval in Saudi Arabia.	PU
10-08	Acarix Provides Update on RHTP and Saudi Arabia Regulatory Process	AQ
09-14	Acarix: Seismocardiography gains further validation in heart failure	AQ
09-11	Peer-Reviewed Study Confirms CADScor System Can Diagnose Heart Failure With Far Fewer False Positives Than Standard Blood Test	AQ
08-17	Acarix (Q2 Review): Laying the groundwork	AQ

1 day	-0.54%
1 week	-4.28%
Current month	-5.26%
1 month	-8.66%
3 months	-25.67%
6 months	-37.23%
Current year	-31.49%

1 week	0.18	0.19
1 month	0.18	0.24
Current year	0.18	0.33
1 year	0.18	0.34
3 years	0.17	0.6
5 years	0.17	1.28
10 years	0.17	26.8

Manager	Title	Age	Since
Aamir Mahmood CEO	Chief Executive Officer	-	01/02/2024
Christian Lindholm CEO	Chief Executive Officer	62	23/02/2018

Director	Title	Age	Since
Louise Janssen-Counotte BRD	Director/Board Member	61	01/01/2020
Kenneth Nelson BRD	Director/Board Member	52	14/05/2024
Tony Das BRD	Director/Board Member	-	14/05/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACARIX AB	-0.54%	-4.28%	-32.50%	-23.34%	23.05M
THERMO FISHER SCIENTIFIC, INC.	+1.61%	+2.44%	+24.90%	+63.22%	256B
DANAHER CORPORATION	+0.89%	+4.38%	+5.91%	+24.58%	163B
INTUITIVE SURGICAL, INC.	-0.38%	+1.41%	-19.42%	+71.51%	155B
BOSTON SCIENTIFIC CORPORATION	-5.84%	-6.91%	-58.58%	-14.32%	65.3B
EDWARDS LIFESCIENCES CORPORATION	+1.06%	+3.95%	+13.56%	+48.73%	52.35B
SIEMENS HEALTHINEERS AG	+1.72%	+2.78%	-13.92%	-7.13%	51.93B
VEEVA SYSTEMS INC.	+1.39%	-0.27%	+7.48%	+67.70%	50.75B
AGILENT TECHNOLOGIES, INC.	+2.25%	+4.90%	+23.80%	+76.59%	50.04B
WATERS CORPORATION	+1.78%	+7.69%	+35.57%	+94.84%	46.03B
Average	+0.53%	+1.19%	-1.32%	+40.24%	89.05B
Weighted average by Cap.	+0.85%	+1.68%	+4.17%	+49.58%

	2026 *	2027 *
Net sales	14M 1.41M 1.27M 1.17M 1.06M 1.98M 134M 2.01M 5.58M 70.35M 5.3M 5.19M 223M	32M 3.23M 2.89M 2.68M 2.42M 4.53M 307M 4.58M 12.75M 161M 12.11M 11.85M 510M
Net income	-30.8M -3.11M -2.79M -2.58M -2.33M -4.36M -296M -4.41M -12.27M -155M -11.65M -11.41M -491M	-15.3M -1.54M -1.38M -1.28M -1.16M -2.17M -147M -2.19M -6.09M -76.88M -5.79M -5.67M -244M
Net Debt	-	-